The annual rate of kidney graft loss caused by chronic allograft nephropathy (CAN) has not improved over the past decade. Recent reports suggest that acute renal ischemia results in development of CAN. The goal of the present study was to assess the renoprotective potential and safety of hepatocyte growth factor (HGF) gene transfer using a porcine kidney transplant warm ischemia injury model. Following left porcine kidney removal, 10 min of warm ischemic injury was intentionally induced. Next, the HGF expression vector or vehicle was infused into the renal artery with the renal vein clamped ex vivo, and electric pulses were discharged using bathtub-type electrodes. Kidney grafts were then transplanted after removing the right kidney. Histopathological examination of vehicle-transfected kidney transplant revealed initial tubular injury followed by tubulointerstitial fibrosis. In contrast, HGF-transfected kidneys showed no initial tubular damage and no interstitial fibrosis at 6 months post-transplant. We conclude that electroporation-mediated ex vivo HGF gene transfection protects the kidney against graft injury in a porcine model. Gene Therapy (2005) 12, 815-820.
Introduction
While the overall 1-year graft survival rates for kidney allograft transplantation has improved, the annual rate of kidney graft loss caused by chronic allograft nephropathy (CAN) has remained stable over last decade. 1 CAN may result from perioperative ischemia at the time of transplantation. 2 Azuma et al 3 recently demonstrated the therapeutic effects of hepatocyte growth factor (HGF) in preventing CAN using a well-established rat CAN model. They showed that HGF treatment during the initial 4 weeks after engraftment prevented onset of CAN and associated death and provided long-lasting benefit in terms of graft survival.
Exogenous HGF is very unstable in the blood circulation due to the rapid clearance by the liver. 4 However, we previously demonstrated that HGF gene transfer by electroporation into the rat kidney resulted in amelioration of cyclosporine nephrotoxicity. 5 Therefore, this gene transfer approach represents a useful technique to investigate the therapeutic potential of HGF gene transfer for long-term survival of kidney allograft. The goal of the present study was to determine the effects of HGF gene transfer on graft survival in a porcine model of kidney transplantation under ischemic conditions using electroporation.
Results

Gene transfer into porcine kidney
To investigate the possibility of transferring a foreign gene into porcine kidney, we attempted to transfect the harvested porcine kidney with oligodeoxynucleotide (ODN) labeled with fluorescein isothiocyanate (FITC) by electroporation using bathtub-type electrodes. Following the gene transfer, the kidney was perfused with phosphate-buffered saline (PBS) and examined under a fluorescent microscope, which demonstrated diffuse accumulation of FITC-labeled ODN in the nuclei of glomerular cells (Figure 1a and b) and interstitial cells (Figure 1c and d) , while no fluorescence was observed in untreated kidney (Figure 1e) .
Next, the porcine kidney subjected to the luciferase gene transfer by electroporation ex vivo was autotransplanted and then removed 4 days later to measure the luciferase activity in the renal cortex. Luciferase assay showed 3.5271.04 Â 10 2 RLU/mg protein in the luciferase gene-transfected kidney and no luciferase activity in a vehicle-transfected porcine kidney.
To examine the protective effect of HGF gene transfer on the graft survival, a porcine kidney subjected to the HGF gene transfer by electroporation was autotransplanted, and the contralateral kidney was removed. As previously reported, HGF is expressed in mesangial cells, endothelial cells, and macrophages in the adult kidney, and thereby HGF acts on tubular epithelial cells in a paracrine manner. 6, 7 Immunohistochemical examination revealed that HGF expression was present in glomeruli at 7 days after transfection (Figure 2a and c) , while no staining was observed in the vehicle-transfected transplanted kidney (Figure 2b and d) . Further, enzymelinked immunosorbent assay (ELISA) showed HGF protein expression in the HGF-gene-transfected kidney (5.7571.21 ng/mg tissue), while HGF protein was not detected in vehicle-transfected kidney transplants.
Extent of transfection
To investigate the extent of HGF gene transfection, the kidney, liver, lung, and spleen were removed at 1, 3, and 6 months after the transplantation. Polymerase chain reaction (PCR) analysis demonstrated that the HGF expression vector was present up to 6 months after transplantation, but only in the transplanted kidney and not in other tissues ( Figure 3) . Furthermore, the HGF expression vector was not detected in any tissue from the vehicle-transfected group. Thus, transfection of the HGF gene by electroporation was limited to the transplanted kidney.
Effect of HGF gene transfer on tubulointerstitial injury
Since we observed little harmful effect on electroporation-treated rat kidney except small burns on the surface of the kidney in contact with electrode, 8 the removed kidney was wrapped in gauze, and then immersed in a bathtub-type electrode. As previously reported, 8 we observed no renal injury in glomeruli or tubules in luciferase gene-transfected porcine kidney. Furthermore, burns were not observed on the surface of the kidney by using the gauze. Induction of warm ischemic injury in the transplanted kidney resulted in characteristic histological changes by 1 month, including tubular atrophy and dilation. Vehicle gene transfer had no additional histological damage on the transplanted kidney after 1 month. At 6 months, these lesions were more extensive and included interstitial fibrosis. Assessment of tubulointerstitial damage by immunohistochemical detection of vimentin, a marker for tubulointerstitial damage, showed increased staining in the tubular cells of the vehicle-transplanted kidney (Figure 4a ). In contrast, HGF gene transfer resulted in less tubular cell staining for vimentin (Figure 4b ), suggesting that HGF gene transfer protected tubular cell from warm ischemic injury.
Phenotypic alteration of cells into myofibroblast, which leads to accumulation of extracellular matrix (ECM), can be estimated by immunohistochemical detection of a-smooth muscle actin (aSMA). A significant increase in aSMA was noted in vehicle-transfected kidneys at one month with an even greater increase at 6 months after transplantation ( Figure 4C ). Specifically, aSMA expression was increased in interstitial spaces and at sites surrounding degenerated tubules. In comparison, expression of aSMA was markedly suppressed and limited to blood vessels at 6 months after transplantation in the HGF gene-transfected kidney ( Figure 4D ).
In order to assess the effect of HGF gene transfer on interstitial fibrosis of the transplanted kidney, histological analysis was performed at 1, 3, and 6 months after transplantation. Masson's trichrome staining showed an expanded interstitium at 6 months after transplantation in vehicle-transfected kidney transplants ( Figure 4e ) and only minimal interstitial expansion in HGF-treated transplanted kidneys at a similar time point (Figure 4f ).
The degree of interstitial fibrosis can be quantitatively assessed as fibrotic fractional volume of renal cortex using a computer-aided manipulator on Masson's trichrome-stained sections. Using this method, the vehicle-transfected kidney showed progression of interstitial fibrosis (4.5671.46 and 5.5471.32% at 1 and 6 months after transfection), while HGF-gene-transfected kidneys showed less development of interstitial fibrosis (2.8670.89 and 3.3271.06% at 1 and 6 months, respectively; Po0.001 versus vehicle group).
The effect of warm ischemic injury on renal function was examined. Consistent with the histological changes, the warm ischemic injury slightly increased the serum creatinine and blood urea nitrogen (BUN) of vehicletransfected pigs. However, HGF gene transfer amelio- HGF gene therapy for kidney transplant Y Isaka et al rated the increase of creatinine and BUN at 1 month after transplantation. During the period, serum creatinine and BUN were lower in HGF group than those in control group (Table 1) .
Discussion
The present study demonstrated that electroporationmediated ex vivo transfection of HGF gene into the porcine kidney with reimplantation of the kidney suppressed tubulointerstitial injury and subsequent fibrosis in the context of induced ischemia. Using this technique, we showed specific transfection of FITClabeled ODN into glomeruli and interstitial cells and specific transfection of the HGF gene transfection to the transplanted kidney with persistence at 6 months after transplantation.
The overall 1-year survival rate for renal allografts continues to improve, mainly due to advances in immunosuppressive therapy and in the diagnosis and treatment of acute rejection. However, the annual rate of kidney graft loss caused by CAN has remained stable over the past decade.
1 CAN is characterized by the deterioration of renal allograft function and is associated with typical morphologic changes within the allograft, including glomerulosclerosis, arterial intimal and smooth muscle cell proliferation, tubular atrophy and interstitial fibrosis. 9, 10 Although the underlying mechanisms leading to CAN remain poorly understood, CAN can be induced by ischemia that occurs at the time of kidney transplantation. 2 Ischemic complications can occur either in the context of cadaver-donor kidney transplantation, in which kidneys are removed after cardiac arrest, or with living-donor kidney transplantation from older patients, as these kidneys have less reserve force due to age-related arteriosclerosis.
HGF, a multifunctional polypeptide originally characterized as a potent mitogen for mature hepatocytes in primary culture, is a heterodimeric molecule consisting of a 69 kDa a-chain and a 34 kDa b-chain held together by a disulfide bond. 11, 12 HGF and its specific c-met receptor constitute a signaling system that modulates renal development and maintenance of normal renal structure and function by exerting potent mitogenic, motogenic, morphogenic, and antiapoptotic activities in renal tubular epithelial cells. Recent studies have demonstrated that HGF has numerous functions in diverse cell survival and tissue regeneration. 7 For example, HGF administration prevented cyclosporineinduced acute renal failure and renal tubule degeneration in mice. 13 Further, HGF-treated rats showed less histological injury when renal ischemia was induced by arterial occlusion.
14 HGF also exerts an antiapoptotic effect on tubular epithelial cells 15 and has an antifibrotic effect. 16 Finally, administration of exogenous HGF protein inhibits activation of matrix-producing myofibroblasts, thereby attenuating extracellular matrix deposition and interstitial fibrosis, by suppressing profibrogenic cytokine-transforming growth factor-b1 and its type I receptor expression in vivo. 17 Exogenous HGF is unstable in the circulation due to the rapid clearance by the liver, making maintenance of HGF levels by exogenous administration difficult. 4 Moreover, systemic administration of HGF likely has effects on many different organ systems. Therefore, local administration of HGF via gene transfection is favored for renal protection as (a) only a small amount of the HGF gene is required for introduction, (b) the influence on other organs can be limited, and (c) the gene transfer technique does not require multiple steps for purification or chronic use of an intravenous catheter as would be needed for a protein drug.
The electroporation technique for gene transfer also has certain advantages. Electroporation is free from oncogenicity, immunogenicity, and cytotoxicity of viral vectors. In addition, electroporation-mediated gene transfer techniques show significantly higher transfection efficiency than the HVJ liposome method. 18 This technique has already been validated in the rat kidney, where HGF gene transfer by electroporation resulted in amelioration of cyclosporine nephrotixicity. 5 In this paper, we showed the diffuse transfection of FITC-labeled ODN into glomeruli and interstitial cells. We previously reported that FITC-ODN were accumulated in the nuclei of the glomeruli and also detected in some interstitial cells after transferring FITC-ODN by electroporation. 8 In the previous report, 8 we infused FITC-ODN solution into the rat kidney in a one-shot manner and renal vein was clamped just after injection. In the present paper, however, FITC-ODN solution was infused into the removed porcine kidney via the renal artery after clamping of the renal vein and ureter. During the injection with clamping renal vein and ureter, the kidney became expanded and stiff. The stress of an increase in intrinsic renal pressure might induce the diffuse distribution of DNA solution into interstitial spaces probably via peritubular capillary network. We speculate that the difference in intrinsic hydrostatic renal pressure between the previous report and the present findings affected the distribution of DNA into interstitial spaces, and electroporation helped the entry of DNA across the plasma membrane. In addition, we showed the presence of expression vector in transplanted kidney up to 6 months ( Figure 3) . Therefore, we performed ELISA to examine the HGF protein expression, but significant HGF protein was not detected 6 months after transfection. The existing expression vector was not functional at 6 months probably due to gene silencing. Similar instability of expression has been found using other gene transfer method. 18 However, we demonstrated the therapeutic effects of HGF gene transfer on renal function of transplanted kidneys. Therefore, our observations suggest that the initial prevalence of HGF HGF gene therapy for kidney transplant Y Isaka et al may be sufficient to prevent chronic allograft nephropathy. The ex vivo gene transfer method of the present study has several advantages over an in vivo gene transfer method. First, ex vivo techniques allow introduction of a gene after removing a kidney for transplantation, thereby limiting the exposure of other organs to the gene vector. Second, the systemic influence of electric shock required for electroporation (eg, burns or muscle contractions) can be obviated. Third, the procedure can be performed during transplantation, and thus no complicated manipulations, such as puncture into renal artery and insertion of cannula, are required. Finally, the method is also suitable in the context of xenogenic transplantation and could potentially be conducted for other organs, including the liver, heart, and lung.
Methods Animals
Gottingen minipigs (Miniature Swine/CSK: CSK Research Park, Inc., Suwa, Japan) weighing 15-20 kg were used. They were kept in an air-conditioned room maintained at a temperature of 22721C and a humidity of 50-60%. They were housed in individual stainless steel cages and fed NS commercial diet (Nisseiken Co., Ltd) 400 g/day and tap water ad libitum. All animals used in this study were treated in accordance with SLA ethical guidelines for animal care and handling.
Gene transfer into porcine kidney
To investigate the efficacy of foreign gene transfer into the porcine kidney, we infused ODNs (12 base pairs) labeled with FITC at the 5 0 -terminus (1.8 mg) in 20 ml of PBS into the harvested porcine kidney via the renal artery after clamping of the renal vein and ureter (n ¼ 3). Next, the kidney wrapped in gauze was immersed in a bathtub-type electrode with PBS for electroporation with a square-shaped voltage (50 V, 100 ms) six times with intervals of 900 ms. 8 At 10 min after the gene transfer, the kidney was perfused with PBS and examined under a fluorescent microscope.
To examine the transgene expression by this gene transfer method, an expression vector carrying a luciferase gene (pCAGGS-Luc) was constructed by cloning the luciferase gene isolated from pGL3 vector (Promega, Madison, WI) into the EcoRI-BamHI site of pUC-CAGGS vector 19 driven by the cytomegalovirus enhancer and chicken b-actin promoter. Either pCAGGS-Luc (1.8 mg) or vehicle was introduced into porcine kidney, similar to above (n ¼ 3 in each group). The porcine kidney was autotransplanted and then removed 4 days after the gene transfer to measure luciferase activity in the renal cortex. 8 The protein content of the renal cortex was measured at the same time and used to correct the luciferase expression level in the renal cortex.
HGF gene transfer into transplanted porcine kidney
To examine the protective effect of HGF gene transfer on graft survival, an expression vector was constructed by inserting the XbaI-BamHI fragment containing fulllength cDNA of HGF into pUC-CAGGS (pCAGGS-HGF). After abdominal section of miniature pigs under anesthesia, the left kidney was removed from each animal. Warm ischemic injury was intentionally introduced in the harvested kidney using perfusion with University of Wisconsin (UW) solution solution at room temperature for 10 min before introduction of pCAGGS-HGF (1.8 mg) or vehicle vector. Next, the porcine kidney was autotransplanted, and the contralateral kidney was removed (n ¼ 15 in each group).
HGF gene expression was examined by immunohistochemistry and ELISA 20 at 7 days after transfection (n ¼ 3 in each group).
To determine the length of time in which the transfected pCAGGS-HGF vector persists, the kidneys, liver, lungs, and spleen were removed at 1, 3, and 6 months after transplantation. Presence of the transfected HGF expression vector was examined in each organ by PCR analysis. The DNA extracted from liver, lung, or spleen or the pCAGGS-HGF-or vehicle-transfected kidney was subjected to PCR using two primers specific for pCAGGS-HGF plasmid vector (5 0 -TGTTGCCGGGAA GCTAGAGT-3 0 and 5 0 -ACATTTCCGTGTCGCCCTTA-3 0 ), which yields a 600 bp fragment. Each cycle consisted of 941C for 30 s, 551C for 1 min, and 721C for 1 min. After 30 cycles, the PCR product was analyzed, and pCAGGS-HGF plasmid vectors were used as positive controls.
For renal morphological studies, kidney transplants treated with HGF-or vehicle gene transfer were fixed in 4% paraformaldehyde and embedded in paraffin (n ¼ 3 at each time point in each group.). Sections (4 mm) were stained with Masson's trichrome reagent. Immunohistochemical stains for vimentin and aSMA were performed using a streptavidin biotin-staining method (Vector ABC kit; Vector Laboratories). Mouse anti-vimentin and antiaSMA monoclonal antibodies (Immunotech, Marseilles, France) were used.
The area of the fibrotic lesion of interstitium was determined in sections stained by Masson's trichrome method to stain collagen fibers (in light blue) in the interstitial space. Under high-power magnification ( Â 400), 10 nonoverlapping fields from the cortical region were selected at random and analyzed by an observer unaware of the experimental protocol. The fibrotic areas in the interstitium were highlighted on digitized images using a computer-aided manipulator (microscope; Leitz DM IRB, software, Quantimet 500+; Leica, Tokyo, Japan). The fibrotic area relative to the total area of the field was calculated as a percentage.
Serum creatinine and blood urea nitrogen were measured 1 month, 3 months, and 6 months after transplantation. The measurements for serum creatinine and blood urea nitrogen were carried out by enzyme method and urease-indophenol method, respectively.
Statistical analyses
All values are expressed as means7s.d. Statistical significance was evaluated using Mann-Whitney test. A P-value of o0.05 was considered significant.
